Table 1.
Clinicopathological characteristics and expression of FOXD2-AS1 in studied PTC patients
| Clinicopathological variables features | FOXD2-AS1 expression | P-value | ||
|---|---|---|---|---|
|
| ||||
| Low expression (n = 68) | High expression (n = 92) | |||
| Age (years) | ≤45 | 40 (58.8) | 64 (69.6) | 0.150 |
| >45 | 28 (41.2) | 28 (30.4) | ||
| Gender | Male | 37 (62.5) | 56 (67.2) | 0.413 |
| Female | 31 (37.5) | 36 (32.7) | ||
| Multicentric Cancer | Single | 35 (67.5) | 40 (58.2) | 0.316 |
| Foci | Multi | 33 (32.5) | 52 (41.8) | |
| TNM stage | Stage I-II | 39 (57.3) | 35 (38.1) | 0.015 |
| Stage III-IV | 29 (42.6) | 57 (61.9) | ||
| Surgical procedure | Subtotal thyroidectomy | 36 (52.9) | 50 (54.3) | 0.859 |
| Thyroidectomy | 32 (47.1) | 42 (45.7) | ||
| Tumor size(mm) | >5 | 27 (39.7) | 25 (27.1) | 0.094 |
| <5 | 41 (60.3) | 67 (72.9) | ||
| Lymph metastasis | No | 45 (66.2) | 42 (45.7) | 0.009 |
| Yes | 23 (33.8) | 50 (54.3) | ||